IGWM
MIST icon

ICA Group Wealth Management’s Milestone Pharmaceuticals MIST Stock Holding History

ICA Group Wealth Management’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-200
Closed -$358 – 1095
2024
Q1 		$358 Hold
200
– – ﹤0.01% 1308
2023
Q4 		$334 Buy
+200
New +$543 ﹤0.01% 1301
2023
Q3 		– Sell
-100
Closed -$285 – 802
2023
Q2 		$285 Hold
100
– – ﹤0.01% 1284
2023
Q1 		$394 Buy
+100
New +$366 ﹤0.01% 1212

Other funds holding MIST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AFA
Alta Fundamental Advisers New York $265M AUM 98.61% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

ICA Group Wealth Management's MIST Position: Q2 2024 in Review

ICA Group Wealth Management sold out of Milestone Pharmaceuticals (MIST) in Q2 2024, closing a stake of 200 shares — an estimated $358 sold.

ICA Group Wealth Management first reported a position in MIST in Q1 2023 and held it in 4 quarters. The position peaked at $394 in Q1 2023. 40 funds tracked by Wall St. Rank hold MIST as of Q2 2024.

  • ICA Group Wealth Management reported no remaining Milestone Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • ICA Group Wealth Management sold 200 Milestone Pharmaceuticals shares in Q2 2024, an estimated $358.
  • ICA Group Wealth Management first reported a position in Milestone Pharmaceuticals in Q1 2023 and held it in 4 quarters.
  • ICA Group Wealth Management's Milestone Pharmaceuticals position peaked at $394 in Q1 2023.
  • 40 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2024.

Based on ICA Group Wealth Management's 13F filing for Q2 2024, filed 8 Aug 2024.